- This event has passed.
EphMRA Switzerland Online Meeting – Innovation has to prove its worth – Putting tech under the microscope – time for an augmented approach?
September 28 @ 1:45 pm – 2:15 pm
This meeting is taking place in CET
Speakers: Carolyn Chamberlain, Commercial Director & Mike Pepp, Account Director, Blueprint Partnership
Are you interested in understanding which, if any, technologies will bring deeper, richer insights vs ‘human’ classical approaches alone?
Carolyn and Mike will share the results of a self-funded study to show whether technology can bring incremental value in healthcare primary research in the field of obesity.
In their study, they will explore, compare and contrast 2 different technology-based analysis tools (sentiment analysis and voice emotion analysis) with the classical human approach.
So will technology replace human analysis and commercial story telling? Join Carolyn and Mike to find out!
Carolyn Chamberlain, Commercial Director
With a track record of more than 20+ years of experience in pharmaceutical market research, both client and agency side, working in a variety of roles.
Her career began at AstraZeneca Global where she led insights teams within CV and Oncology for over a decade. Her contributions helped drive the growth of key blockbusters. Carolyn is a well-known commercial market leader in qualitative and quantitative insight in both the UK and overseas. She is passionate about engaging with a diverse range of stakeholders and driving debate in our industry. We must continue to positively disrupt and transform our industry!
Over the last 15 years, she held senior commercial and leadership positions with IPSOS, Kantar Health and the Adelphi Group, whilst also being a key contributor to EphMRA, PMRC and the BHBIA.
Mike Pepp, Account Director
Mike brings over 20 years of experience in pharma market research. He’s trained in psychology and neurolinguistic programming. He has previously held senior positions at Branding Science and Context Research.
Mike has extensive experience in patient research – he is fascinated by uncovering conscious and unconscious patient motivators.
Mike is highly valued by his clients for providing excellent quality research skills, superior thinking, insights that guide future thinking and strong leadership across his projects and is a regular presenter on the conference circuit.